FGF-23 participates in activated vitamin D circulating levels reduction [76], and an association between increased FGF-23 and reduced Klotho with vascular calcification and aortic valve calcification in CKD patients was previously reported [77,78,79]. This evidence concerns the gene FGF23 and chronic kidney disease.